Prosthetic hip infection due to Campylobacter jejuni .
Andrew Joseph SimmsTakaaki KobayashiPatrick V SchwartzhoffPoorani SekarPublished in: BMJ case reports (2022)
A woman in her 60s with a left hip prosthesis was presented with left hip pain and fever. She had an elevated white blood cell count and inflammatory markers. Synovial fluid Gram stain demonstrated curved Gram-negative rods identified as Campylobacter jejuni The patient initially refused surgery and after 3 months underwent one-stage exchange after which she was treated with 12 weeks of levofloxacin. Her inflammatory markers normalised and she was clinically doing well at her 6-month follow-up. C. jejuni is a rare cause of prosthetic joint infection and should be included in the differential diagnosis when a patient has risk factors even without significant preceding gastrointestinal symptoms. Per most recent Infectious Diseases Society of America guidelines, treatment after one-stage revision includes 4-6 weeks of intravenous antimicrobials followed by possible oral suppression therapy, while the European guidelines recommend 12 weeks of orally bioavailable antibiotics.
Keyphrases
- gram negative
- total hip arthroplasty
- multidrug resistant
- infectious diseases
- case report
- risk factors
- gestational age
- clinical practice
- minimally invasive
- total knee arthroplasty
- chronic pain
- single cell
- antimicrobial resistance
- cell therapy
- pain management
- coronary artery bypass
- high dose
- stem cells
- neuropathic pain
- sleep quality
- atrial fibrillation
- pseudomonas aeruginosa
- percutaneous coronary intervention
- staphylococcus aureus
- bone marrow
- surgical site infection